Post-Nasal Drip: Potential causes of post-nasal drip are infection, allergies, or an abnormality in your nasal structures. Antihistamine decongestants are the most common over-the-counter treatment for this symptom. Unfortunately, post-nasal drip is difficult to treat, therefore we recommend making...
摘要: In this article, the author offers suggestions for using the drugs Flonase and Nasacort to stop sneezes, sniffles, and post-nasal drip and also mentions that the drugs to be used as nasal sprays the side effects of the drugs are very low....
nasalopiateopioidspharmacokineticsLack of non-injectable naloxone formulations has impeded widespread take-home provision for the prevention of heroin/opioid overdose deaths. For non-injectable formulations that are finally being investigated, rapid onset of action and sufficient bioavailability will be vital...
The sights, sounds and smells of Christmas stay with many of us for a lifetime. Perhaps cinnamon in your nasal cavity automatically takes you back to Grandma’s kitchen. Or at the first glimpse of a decorated tree, you’re transported to your childhood living room. For young ones, ...
Conclusions Concentrated naloxone nasal spray has a promising pharmacokinetic profile, with substantial bioavailability. Its early absorption time-course suggests that concentrated nasal naloxone is suitable for emergency administration in the community, where rapid restoration of respiratory function is essential...
Finally, the time needed to reach its peak diameter after cuff release (i.e., time to peak dilation) was calculated. Carotid artery reactivity (CAR) to a cold pressure test was only assessed 4 h post-drink using the same echo-Doppler device. The left common carotid artery was scanned in...
classifier was 0.93, and the coefficients of the explanatory variables were: best-corrected visual acuity (BCVA) at baseline was 0.66, BCVA at first resolution of ME was 0.51, age was 0.21, the average brightness of the ellipsoid zone (EZ) was −0.12, the intactness of the external ...
A comparison of the efficacy of apathogenic genotype I (V4) and lentogenic genotype II (LaSota) strains of live Newcastle disease virus (NDV) vaccines was performed following vaccination with pathogen-associated molecular pattern (PAMP) H9N2 avian influenza vaccine and challenge with velogenic NDV ge...